Yiwen Liang Selected Research

IRAK1 inhibitor Jh-X-119-01

1/2022

Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiwen Liang Research Topics

Disease

2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2021
1	Cognitive Dysfunction 04/2022
1	Leukoencephalopathies 04/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022
1	Inflammation (Inflammations) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Fibrosis (Cirrhosis) 10/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021
1	Coronavirus Infections 10/2021
1	Severe Acute Respiratory Syndrome 10/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2021
1	Pneumonia (Pneumonitis) 10/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021
1	Infections 01/2021
1	Influenza in Birds (Avian Flu) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2018
1	Margins of Excision 02/2018

Drug/Important Bio-Agent (IBA)

1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	IRAK1 inhibitor Jh-X-119-01IBA 01/2022
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2022
1	CollagenIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	glucose utilization inhibitor (IGU)IBA 10/2021
1	iguratimodIBA 10/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	Biological ProductsIBA 01/2021

Therapy/Procedure

1	Cell Transplantation 01/2022
1	Cystectomy 02/2018
1	Length of Stay 02/2018